Literature DB >> 10099830

Human melanoma cell line UV responses show independency of p53 function.

T Haapajärvi1, K Pitkänen, M Laiho.   

Abstract

UV radiation-induced mutation of the p53 gene is suggested as a causative event in skin cancer, including melanoma. We have analyzed here p53 mutations in melanoma cell lines and studied its stabilization, DNA-binding activity, and target gene activation by UVC. p53 was mutated in three of seven melanoma cell lines. However, high levels of p53 were detected in all cell lines, including melanoma cells with wild-type p53, with the exception of one line with a truncated form. Upon UV induction, p53 accumulated in lines with wild-type p53, and p53 target genes p21Cip1/Waf1, GADD45, and mdm2 were induced, but the induction of p21Cip1/Waf1 was significantly delayed as compared with the increase in p53 DNA-binding activity. However, despite p53 target gene induction, p53 DNA-binding activity was absent in one melanoma line with wild-type p53, and p53 target genes were induced also in cells with mutant p53. In response to UV, DNA replication ceased in all cell lines, and apoptosis ensued in four lines independently of p53 but correlated with high induction of GADD45. The results suggest that in melanoma, several p53 regulatory steps are dislodged; its basal expression is high, its activation in response to UV damage is diminished, and the regulation of its target genes p21Cip1/Waf1 and GADD45 are dissociated from p53 regulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10099830

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  15 in total

1.  Similar nucleotide excision repair capacity in melanocytes and melanoma cells.

Authors:  Shobhan Gaddameedhi; Michael G Kemp; Joyce T Reardon; Janiel M Shields; Stephanie L Smith-Roe; William K Kaufmann; Aziz Sancar
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

Review 2.  Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells.

Authors:  Yunyi Kong; Suresh M Kumar; Xiaowei Xu
Journal:  Arch Pathol Lab Med       Date:  2010-12       Impact factor: 5.534

3.  Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells.

Authors:  Tatyana A Zykova; Feng Zhu; Chengrong Lu; LeeAnn Higgins; Yasuaki Tatsumi; Yasuhito Abe; Ann M Bode; Zigang Dong
Journal:  Clin Cancer Res       Date:  2006-12-01       Impact factor: 12.531

4.  Design, synthesis and initial biological evaluation of a novel pladienolide analog scaffold.

Authors:  Mahesh Kumar Gundluru; Alan Pourpak; Xiaoli Cui; Stephan W Morris; Thomas R Webb
Journal:  Medchemcomm       Date:  2011-01-01       Impact factor: 3.597

5.  EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.

Authors:  Tao Fan; Shunlin Jiang; Nancy Chung; Ali Alikhan; Christina Ni; Chyi-Chia Richard Lee; Thomas J Hornyak
Journal:  Mol Cancer Res       Date:  2011-03-07       Impact factor: 5.852

6.  The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.

Authors:  Hong Yu; Ronan McDaid; John Lee; Patricia Possik; Ling Li; Suresh M Kumar; David E Elder; Patricia Van Belle; Phyllis Gimotty; Matt Guerra; Rachel Hammond; Katharine L Nathanson; Maria Dalla Palma; Meenhard Herlyn; Xiaowei Xu
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

7.  High-level expression of wild-type p53 in melanoma cells is frequently associated with inactivity in p53 reporter gene assays.

Authors:  Roland Houben; Sonja Hesbacher; Corinna P Schmid; Claudia S Kauczok; Ulrike Flohr; Sebastian Haferkamp; Cornelia S L Müller; David Schrama; Jörg Wischhusen; Jürgen C Becker
Journal:  PLoS One       Date:  2011-07-08       Impact factor: 3.240

8.  Antiproliferative Effect of Rottlerin on Sk-Mel-28 Melanoma Cells.

Authors:  Elena Daveri; Giuseppe Valacchi; Roberta Romagnoli; Emilia Maellaro; Emanuela Maioli
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-28       Impact factor: 2.629

9.  NeuroD1 regulation of migration accompanies the differential sensitivity of neuroendocrine carcinomas to TrkB inhibition.

Authors:  J K Osborne; J E Larsen; J X Gonzales; D S Shames; M Sato; I I Wistuba; L Girard; J D Minna; M H Cobb
Journal:  Oncogenesis       Date:  2013-08-19       Impact factor: 7.485

10.  Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53.

Authors:  S C Naumann; W P Roos; E Jöst; C Belohlavek; V Lennerz; C W Schmidt; M Christmann; B Kaina
Journal:  Br J Cancer       Date:  2009-01-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.